HPK1 Influences Regulatory T Cell Functions

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Hematopoietic progenitor kinase 1 (HPK1) negatively regulates T-cell receptor (TCR) signaling.
• HPK1 deficiency enhances antitumor immunity, particularly with anti-PD-L1 therapy.
• Regulatory T cells (Tregs) suppress anti-tumor immunity.

Purpose of the Study:

• To investigate the role of HPK1 in Treg function.
• To determine if HPK1 deficiency impacts Treg-mediated suppression of anti-tumor immunity.

Main Methods:

• Comparison of Treg function in HPK1-deficient mice versus wild-type mice.
• Analysis of TCR-induced signaling pathways (Erk MAPK, p65/RelA NF-κB) in Tregs.
• Multiplex cytokine analysis of stimulated Tregs.

Main Results:

• HPK1-deficient Tregs are elevated in number but exhibit impaired suppressive function.
• HPK1-deficient Tregs show enhanced and sustained Erk MAPK and p65/RelA NF-κB phosphorylation upon TCR engagement.
• HPK1-deficient Tregs display an aberrant cytokine profile, including increased IL-2, IFN-γ, CCL3, and CCL4 production.

Conclusions:

• HPK1 plays a critical role in maintaining Treg suppressive function.
• HPK1 deficiency leads to aberrant Treg signaling and cytokine production, contributing to enhanced anti-tumor immunity.
• HPK1 represents a potential novel immunotherapeutic target for cancer treatment.